Company Overview

Arvaya Healthcare Limited (formerly Bijoy Hans Limited) has undergone significant corporate restructuring during FY 2025-26, transitioning into the healthcare sector through major acquisitions and capital reorganization.

Financial Performance

Standalone Results (₹ in Lacs): The company reported zero revenue from operations and a net loss of ₹119.73 lacs for FY26, contrasting with a profit of ₹13.61 lacs in FY25. This deterioration reflects the transitional phase as the company shifted from its previous business model.

Consolidated Performance: Following the acquisition of three healthcare subsidiaries, the consolidated financials show revenue of ₹911.33 lacs and profit after tax of ₹90.38 lacs (total comprehensive income of ₹91.11 lacs), indicating the acquired businesses are operational and contributing positively.

Major Corporate Developments

The company completed the 100% acquisition of three healthcare entities on 4 March 2026:

  • Health Secure Hospitals Private Limited (hospital management services)
  • Arvaya Healthtech & Wellness Private Limited (healthcare and wellness services)
  • Tec-Pool Solutions Private Limited (IT-enabled healthcare solutions)

Consideration Structure: Total acquisition value of ₹6,065.23 lacs through issuance of 4,05,21,836 equity shares at ₹12.50 per share (₹4,052.18 lacs) plus cash payment of ₹250 lacs and deferred consideration of ₹750 lacs.

Capital Structure Changes

The company significantly expanded its capital base:

  • Authorized share capital increased from ₹10 crore to ₹200 crore
  • Paid-up capital increased from ₹3 crore to ₹48.02 crore through preferential allotment and acquisition-related share issuance
  • Total outstanding shares reached 4,80,21,857 as of 31 March 2026

AGM Agenda and Shareholder Approvals

The 41st Annual General Meeting is scheduled for 21 September 2026 with key agenda items:

Ordinary Business: Adoption of standalone and consolidated financial statements, re-appointment of Mr. Kaushal Uttam Shah as Managing Director

Special Business:

  • Approval for material related party transactions totaling ₹370 crore with nine related parties including promoters and subsidiaries for FY 2026-27
  • Acquisition of intellectual property from DEFIB Institute of Health Solutions LLP for up to ₹10 crore using rights issue proceeds

Board and Management Changes

Significant leadership changes occurred during FY26 with multiple director resignations and appointments. Mr. Kaushal Uttam Shah emerged as the controlling promoter following a change in control. Key managerial personnel changes included appointment of Mr. Ranganath Abhiram as CFO and Mrs. Guinea Agrawal as Company Secretary.

Regulatory Compliance and Governance

The company maintains compliance with SEBI Listing Regulations and Companies Act requirements. Notably, 90.07% of shares remained in physical form as of 31 March 2026, requiring additional compliance efforts for physical shareholders regarding PAN, KYC, and nomination details.

Future Outlook

The company has positioned itself in the healthcare sector through strategic acquisitions and capital expansion. The upcoming AGM approvals for substantial related party transactions and IP acquisition will be critical for executing the company's healthcare business strategy in FY27.